Trademarkia Logo

United Kingdom

£
Pre-Publication

on 29 Mar 2022

Last Applicant/ Owned by

ImmunoVaccine Technologies Inc.

130 Eileen Stubbs Avenue, Suite 19

Dartmouth, Nova Scotia, , B3B 2C4

Serial Number

UK00003771343 filed on 29th Mar 2022

Correspondent Information

Potter Clarkson LLP

The Belgrave Centre, Talbot Street

Nottingham,

NG1 5GG

DPX

drug delivery technology in the form of lipid vesicles, that can be formulated with a wide variety of bioactive molecules and results in a specific im Read More

Classification Information


Class [5]
Pharmaceutical Products


Drug delivery technology in the form of lipid vesicles, that can be formulated with a wide variety of bioactive molecules and results in a specific immune response.

Class [42]
Computer & Software Services & Scientific Services


Pharmaceutical research and development; laboratory research in the fields of chemistry and biochemistry; research in the field of pharmaceutical drug delivery; medical research; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; hosting websites with information in the field of pharmaceutical research and development.

Mark Details


Serial Number

UK00003771343

Mark Type

Word

Kind of mark

Individual